rTMS Device for Improvement of Obsessive and Compulsive Behaviors

Phase 3 trials show orexin agonist oveporexton improves cognition, sleep, and daily function in narcolepsy type 1

Phase 3 clinical trials show that the investigational drug oveporexton (TAK-861), an oral orexin receptor 2 agonist developed by Takeda, imp

Study reveals cell type-specific neural mechanism behind rapid antidepressant effects of transcranial magnetic stimulation in mice

This article presents a scientific study investigating the neural mechanisms behind the rapid antidepressant effects of accelerated intermit

Clinician's guide to insomnia-related technologies and devices

This article, authored by the AASM Emerging Technology Committee, provides clinicians with a comprehensive overview of insomnia-related tech

Elemind: Wearable Neurotechnology Device for On-Demand Sleep Enhancement

Elemind is a wearable neurotechnology device designed to help users achieve faster sleep on-demand. The product uses neurotechnology to modu

Obsessive-Compulsive and Related Disorders in Children and Young People: Current Evidence and Clinical Approaches

Obsessive-Compulsive and Related Disorders in Children and Young People: Current Evidence and Clinical Approaches

Wave Neuroscience's MeRT (EEG-Guided TMS) Receives FDA Clearance for PTSD Treatment

Wave Neuroscience's MeRT (EEG guided TMS) has received FDA clearance for the treatment of PTSD. The article features an interview with the p